The 0-antigen of Salmonella typhimurium is synthesized and polymerized on a membrane glycosyl carrier lipid (P-GCL) before transfer to the lipopolysaccharide (LPS) core (12, 20, 21) . The first enzyme of 0-antigen synthesis, galactose-diphosphoglycosyl carrier lipid (GCL-PPGal) synthetase, catalyzes the synthesis of GCL-PP-Gal from uridine diphosphogalactose (UDPGal) and P-GCL and also catalyzes an exchange reaction between the uridylyl moiety of UDPGal and uridine monophosphate (UMP): [3H]UMP + UDPGal [3 HUDPGal + UMP (14) . The exchange reaction is a sensitive measure of enzyme activity. GCL-PP-Gal synthetase is analagous to the first enzyme of peptidoglycan synthesis, P-NAcMur-pentapeptide translocase (phospho-N-acetylmuramylpentapeptide translocase), an enzyme that catalyzes the synthesis of GCL-PP-NAcMur-pentapeptide (4, 19, 23) . The interaction of each enzyme with a C55 isoprenoid alcohol phosphate carrier lipid led to the theory that the availability of P-GCL within the membrane may coordinate the syntheses of peptidoglycan and LPS, two major components of the outer membrane of S. typhimurium (8) .
We decided to examine the role of P-GCL in the control of outer membrane synthesis by estimating the degree of competition between P-NAcMur-pentapeptide translocase and GCL-PP-Gal synthetase for carrier lipid in intact membrane preparations. Our initial approach was a study of properties of GCL-PP-Gal synthetase (14) . The studies reported here examine the effect of the accumulation of glycosylated carrier lipid on the nucleotide exchange reactions. Through a survey of several mutant strains it became clear that the expression of GCL-PP-Gal synthetase activity is highly sensitive to the state of other enzymes of LPS synthesis, including those catalyzing the formation of the core polysaccharide.
are derivatives of SL1620, a streptomycin-resistant methionine-tryptophan auxotroph obtained from B.A.D. Stocker, Stanford University. Dr. Stocker also supplied two rfa mutants, SL1033 and SL1004, which were isolated from SL1620 and lack the LPS core enzymes galactosyl-I-transferase and glucosyl-I-transferase, respectively. In addition, SL1033 lacks the enzyme phosphomannose isomerase (pmi). Diaminopimelic acid-requiring derivatives of SL1620 and the rfa mutants were isolated after penicillin selection (C. W. Shuster and J. O'Neil, manuscript in preparation). Two Hfr strains, SA536 and SA534, were obtained from K. Sanderson (Calgary University).
Phage FO was obtained from Dr. Stocker, phage C21 from M. J. Osborn, University of Connecticut, phage P22c2 from M. Levine, University of Michigan, and P22al from P. E. Hartman, Johns Hopkins University.
Preparation of LPS mutant strains. The introduction of mutations that affect the synthesis of wild-type LPS was essential to this study. The LPS core structures and phage sensitivity patterns that result from the mutational lesions are summarized in Table 2 (15) .
Preparation of membranes and measurement of exchange reactions. Overnight cultures of bacteria were diluted 10-fold into nutrient broth (Difco) and grown to mid-logarithmic phase (optical density at 600 nm = 0.4). The growth medium contained diaminopimelic acid, 20 jg/ml, when required. The cells were collected by centrifugation, washed once in 0.05 M tris(hydroxymethyl)aminomethane-hydrochloride, pH 7.6, and broken by passage through a French press. The particulate fraction was recovered by centrifugation at 200,000 x g for 45 min. Membrane fractions were suspended in 0.05 M tris(hydroxymethyl)aminomethanehydrochloride, pH 7.6, and stored at 4 C. Protein concentrations of the particulate suspensions were determined by the method of Lowry et al. (7) .
Nucleotide exchange reactions catalyzed by GCL-PP-Gal synthetase and P-NAcMur-pentapeptide translocase were measured by the conversion of [8H JUMP into [3H JUDPGal and [3H ]UDPNAcMurpentapeptide. The products were treated with alkaline phosphatase and separated by diethylaminoethylcellulose column chromatography as described previously (13) . The specific activity of the reactions is defined as the rate per milligram of membrane protein and has the units moles per liter minute per milligram. In the experiments reported, the substrate for the translocase exchange reaction was the lysinecontaining UDPNAcMur-pentapeptide isolated from penicillin-treated cultures of Staphylococcus aureus (17) . Recently, UDPNAcMur-pentapeptide containing diaminopimelic acid has been prepared by the addition of D-alanyl-D-alanine to UDPNAcMur-tripeptide using the ligase enzyme from Escherichia coli. UDPNAcMur-tripeptide was isolated from cultures of Bacillus cereus incubated with D-cycloserine. The rate of the nucleotide exchange reaction and the apparent Km for the nucleotide sugar substrate are Radiochemical determinations were performed as previously described (14) .
RESULTS
Effect of GCL-PP-GalRham accumulation on GCL-PP-Gal synthetase. GCL-PP-Gal synthetase catalyzes both the synthesis of GCL-PP-Gal and a nucleotide exchange reaction between UMP and UDPGal. Clearly, P-GCL is required for the first activity because it is a substrate for synthesis. However, a P-GCL requirement for the nucleotide exchange reaction was not obvious. We decided to measure the rates of the nucleotide exchange reaction in membranes that have accumulated glycosylated carrier lipid and have less available P-GCL to determine if the enzyme requires free P-GCL for both activities.
The accumulation of glycosylated P-GCL can be controlled in galE mutants. These mutants cannot synthesize UDPGal and, therefore, do not synthesize 0-antigen intermediates in galactose-free media. However, the addition of exogenous galactose allows the accumulation of UDPGal and GCL-PP-Gal and ultimately the synthesis of 0-antigen which can be transferred to newly synthesized LPS core. The addition of galactose to galE pmi double mutants results in the synthesis of GCL-PP-GalRham intermediates that accumulate on the cytoplasmic membrane. Use of the double mutant ensures accumulation of glycosylated P-GCL and depletion of carrier lipid pools, because the product synthesized in response to galactose cannot be polymerized or transferred to LPS core with any degree of efficiency.
The galE pmi double mutant CW166 was constructed to study the effect of GCL-PP-Gal Rham accumulation on the nucleotide exchange reactions. The exchange reaction catalyzed by GCL-PP-Gal synthetase is drastically reduced when membranes are prepared from CW166 cultures exposed to 2 x 10-3 M galactose for 10 min before the cells were collected and membrane fractions were prepared ( Table 3 ). The first enzyme of peptidoglycan synthesis, PNAcMur-pentapeptide translocase, catalyzes an exchange reaction analogous to that catalyzed by GCL-PP-Gal synthetase. It is extremely interesting that the accumulation of GCL-PP-GalRham has no effect on the translocase exchange reaction. It is apparent that sufficient carrier lipid is available to maintain normal levels of the UDPNAcMur-pentapeptide exchange reaction even though the UDPGal-UMP exchange reaction is reduced by 87%.
The reduction in GCL-PP-Gal synthetase activity in the galE pmi double mutant persists as long as exogenous galactose is present, because glycosylated P-GCL continues to accumulate. In contrast, only transient reductions are observed in galE (pmi+) mutants. Membranes prepared from CW115 (galE) 10 min after the addition of 10-3 M galactose show a 60 to 80% reduction in the rate of the UDPGal-UMP exchange reaction. When the cells are grown in exogenous galactose for longer periods of time, the rate of the exchange reaction increases and approaches the rate measured in wild-type cultures. The recovery of GCL-PPGal synthetase activity can be explained because, in contrast to the situation in the galE pmi double mutants, LPS core is synthesized by galE mutants in response to exogenous galactose. Polymerized 0-antigen is transferred to newly synthesized LPS core and P-GCL is regenerated. Presumably, the synthesis of 0-antigen and that of the LPS core are coordinated so that 0-antigen does not accumulate on the carrier lipid.
Effect of GCL-P-Glucose accumulation on the exchange reactions. Two independent enzyme systems that catalyze the glucosylation of the 0-antigen can be expressed in S. typhimurium. The bacterial oafR system is present in this organism but is subject to phase variation, i.e., the random expression within the culture (9 (18) . P22al is a mutant of the wild-type phage which does not code for the synthesis of antigen 1 (24). Membranes from cells infected with this nonconverting phage catalyze the synthesis of GCL-P-Glucose but glucose is not transferred from the carrier lipid to the 0-antigen (C. W. Shuster, J. O'Neil, and K. Rundell, manuscript in preparation). P22al was used to lysogenize galE1368, a strain that contains a temperature-sensitive UDPG epimerase and is sensitive to P22 infection at 25 C but resistant to infection at 37 C. At 37 C UDPGal and UDPG are not interconverted because UDPG epimerase is inactive. Thus, the UDPGal-UMP exchange reaction can be measured in the presence of UDPG. Membranes were isolated from the P22al lysogen (CW171) and the nonlysogenic parent strain and used to determine the effect of GCL-P-Glucose accumulation on P-NAcMur-pentapeptide translo- (Table 4) . The membranes were preincubated with 10-4 M UDPG for 10 min before the addition of the substrates for the nucleotide exchange reactions. The rate of the GCL-PP-Gal synthetase exchange reaction was reduced significantly by the accumulation of GCL-P-Glucose in the membranes from the lysogenic strain. The 20% reduction in the UDPGal-UMP exchange rate observed with membranes from LT2 galE1368 may reflect the low level of oafR activity expected in the culture. Preincubation of the membranes with UDPG has no effect on the rate of the exchange reaction catalyzed by UDPNAcMur-pentapeptide translocase.
GCL-PP-Gal synthetase activity in rfa mutants. Two rfa mutants were examined and found to have barely detectable levels of GCL-PP-Gal synthetase ( Table 5) . One of the mutants, CW112, synthesizes incomplete LPS core and, therefore, has no sites available to accept polymerized 0-antigen from the carrier lipid. The other core-deficient mutant, CW108, would be expected to synthesize only the fragment GCL-PP-GalRham because of a pmi mutation. It seemed likely that the lack of GCL-PP-Gal synthetase activity in the rfa mutants resulted from the accumulation of glycosylated carrier lipid. The accumulation of glycosylated intermediates and consequent reduction of available P-GCL would not occur in galE derivatives of the core-defective strains. However, GCL-PPGal synthetase activity was not restored in recombinants containing both galE and rfa mutations (e.g., CW174 in Table 5 ). These strains have barely detectable levels of GCL-PP-Gal synthetase activity even though the galE mutation would prevent the formation of UDPGal and glycosylated carrier lipid. Thus, the GCL-PP-Gal synthetase activity is reduced in the rfa mutants for reasons other than the accumulation of glycosylated lipid.
The genetic information for LPS core synthesis is far removed from the gene for GCL-PPGal synthetase (Fig. 1) . The gene for GCL-PPGal synthetase is included in the rfb region of the map near the operon for histidine biosynthesis. The genes for the LPS core transferases that are lacking in CW112 and CW108 are within or near the rfa cluster on the genetic map (6). To determine whether secondary mutations in GCL-PP-Gal synthetase had been selected in the LPS core mutants, the wild-type genes for the rfa region were transferred into one of the mutants, CW108. CW108 was mated with SA536 (HfrK6), and Met+ recombinants were selected and screened for inheritance of other genetic information. Several of the recombinants regained the ability to synthesize LPS core, and they are resistant to infection by phage C21, the phage that infects the parent strain, CW108. The recombinants are sensitive to FO but are not sensitive to P22, because the Reduced levels of 0-antigen accumulation by rfa mutants. The synthesis and accumulation of 0-antigen fragments has been described for the rfa mutants SL1004 and SL1033 (2, 11) . Accumulation of 0-antigen fragments on the carrier lipid suggests that GCL-PP-Gal synthetase must be expressed in the mutant cells. However, we observed that the enzyme activity is less than 10% that found in wild-type cells. Because the enzyme activity was determined using membrane preparations, it was possible that normal levels of the enzyme were present in whole cells but the enzyme was only weakly associated with the membrane and was released from the membrane during cell fractionation. Therefore, we determined the rate of GCL-PP-GalRham synthesis in vivo as a measure of the level of GCL-PP-Gal synthetase expression and glycosylated P-GCL accumulation in the rfa mutant CW174. The rate of synthesis of GCL-PP-GalRham by CW174 was compared to that of CW166, a galE pmi double mutant that does not carry an rfa mutation and has normal levels of membrane-associated GCL-PP-Gal synthetase.
["4C ]galactose was added to growing cultures of CW166 and CW174, and the cells were extracted with chloroform-methanol as described by Ames (1). The extracted material was analyzed by thin-layer chromatography on Silica Gel G with chloroform-methanol-NH40H-water (130:50:1:7.2) as a solvent. The R, of GCL-PPGalRham in this system is 0.3 to 0.34, as determined by chromatography of GCL-PPGalRham eluted from columns of diethylaminoethyl-cellulose (acetate form) with 0.4 M ammonium acetate in 99% methanol (3). Chromatography of the extracted products of [4C ]galactose incorporation is essential because galE mutants synthesize large amounts of a galactose-containing compound that is extracted by chloroform-methanol and is not GCL-PP-GalRham. This material remains at the origin after thin-layer chromatography and represents over 50% of the extractable radioactivity.
The rate of synthesis of GCL-PP-GalRham by the rfa mutant CW174 is only 10% that shown by CW166 ( Table 6 ). The decreased synthesis of glycosylated P-GCL reflects the low level of enzyme activity detected by the nucleotide exchange reaction and indicates that the rfa mutation alters synthetase activity in vivo as well as in isolated membrane preparations.
DISCUSSION
Three central concepts have emerged from these investigations of a variety of mutants of LPS synthesis in S. typhimurium. First, the activity of the first enzyme of 0-antigen synthesis, GCL-PP-Gal synthetase, is influenced not only by the availability of P-GCL within the membrane but also by the state of other enzymes of LPS synthesis. Second, the analogous enzyme in peptidoglycan synthesis, P-NAcMurpentapeptide translocase, is relatively unaffected by the accumulation of GCL-PP-GalRham or GCL-P-Glucose. Third, the inhibition of the GCL-PP-Gal synthetase exchange reaction by glycosylated P-GCL suggests that free carrier lipid is essential to the nucleotide exchange reaction.
The inhibition of the UDPGal-UMP exchange reaction by GCL-P-Glucose synthesized in membranes of P22 lysogens strongly suggests that the same pool of P-GCL is available to the P22-specified glucosyl transferase and to GCL-PP-Gal synthetase. This may also be true for the oafR (bacterial) enzymes (9) that catalyze the synthesis of GCL-P-Glucose and antigen 122 production, because UDPG inhibits the UDPGal-UMP exchange reaction slightly in membranes of nonlysogenic strains. The oafR system is poorly expressed in S. typhimurium, and only a portion of the cells within a culture would be expected to exhibit oafR activity.
The interaction of the glucosyl transferase and GCL-PP-Gal synthetase is reminiscent of a phenomenon described in Salmonella anatum lysogenic for the phage E34. Like P22, phage 634 contains the genetic information for a GCL-PGlucose synthetase. S. anatum (34) strains appears to produce less 0-antigen and become more sensitive to phage FO. Wright and Barzilai (22) attribute this effect to the accumulation of GCL-P-Glucose and the consequent reduction in P-GCL pools available for 0-antigen synthesis.
The normal levels of the exchange reaction catalyzed by P-NAcMur-pentapeptide translocase under conditions in which the UDPGal-UMP exchange reaction is inhibited suggests that the two enzymes interact with different pools of P-GCL in vivo. This conclusion assumes that the two enzymes interact with identical carrier lipids and that free P-GCL is required for the translocase exchange reaction. On the basis of experiments conducted with isolated P-GCL, we feel that the same isoprenol carrier lipid can serve as an acceptor for the two enzymes. P-GCL purified by monitoring acceptor activity for GCL-PP-Gal synthetase can be used to synthesize equivalent amounts of GCL-PP-NAcMur-pentapeptide (M. K. Rundell and C. W. Shuster, Fed. Proc., p. 1274, 1974).
Furthermore, the synthesis of GCL-PP-Gal from purified P-GCL is inhibited by greater than 80% when membranes are preincubated with UDPNAcMur-pentapeptide and P-GCL before the addition of UDPGal (M. K. Rundell, Ph.D. thesis, Case Western Reserve University, Cleveland, Ohio 1973) .
The requirements of the translocase exchange reaction in S. typhimurium are being investigated currently, but studies of the lipid-depleted translocase from S. aureus indicate that free P-GCL is required for the nucleotide exchange reaction (13) . Assuming that P-GCL is indeed involved in the translocase exchange reaction, our results suggests that the availability of P-GCL to the translocase and to GCL-PPGal synthetase would have limited value as a mechanism for coordinating the assembly of the Salmonella outer membrane.
The loss of GCL-PP-Gal synthetase activity in the rfa mutants lacking glucosyl-I-transf6rase and galactosyl-I-transferase is not understood but may result from either decreased synthesis of GCL-PP-Gal synthetase or the failure of the 0-antigen enzyme to integrate into the membrane structure and express activity in the mutant strains. The core enzymes appear to interact in vitro with phosphatidylethanolamine and with each other to produce an enzyme complex (5). Possibly, a similar interaction in vivo may provide the membrane structure necessary for functional integration of GCL-PP-Gal synthetase. The rfa mutants should be analyzed for the presence of other enzymes of LPS core and 0-antigen synthesis to determine whether activities other than GCL-PP-Gal synthetase are affected by the mutations in the core glycosyltransferase enzymes.
The rfa mutations in CW112 and CW108 do not prevent the insertion of the P22-mediated GCL-P-Glucose synthetase, because P22 lysogens of the rfa mutants have been constructed and the membranes of the lysogens have normal levels of GCL-P-Glucose synthesis (Shuster and Rundell, unpublished observations). However, the GCL-P-Glucose synthetase is not a bacterial enzyme and is not normally a part of the cytoplasmic membrane. Thus, the glucose enzyme may be peripheral to an enzyme complex and may interact with that complex without forming part of the complex itself.
It would be interesting to select and analyze other rfa mutants to determine whether mutations other than those present in CW108 and CW112 affect GCL-PP-Gal synthetase. If the insertion of the 0-antigen enzyme into the cytoplasmic membrane is determined by the presence of a complex of core glycosyltransferases, rfa mutants that produce nonfunctional enzymes but form appropriate complexes would have GCL-PP-Gal synthetase activity and accumulate 0-antigen fragments on the carrier lipid. If the insertion of GCL-PP-Gal synthetase into the membrane is influenced by the presence of the core enzymes, not all rfa mutants would necessarily affect the expression of GCL-PP-Gal synthetase. We have two uncharacter-ized mutant strains that appear to synthesize incomplete LPS core, as determined by phage sensitivity patterns, but have normal levels of GCL-PP-Gal synthetase exchange reaction. However, the lesions present in these strains have not been determined and it is not known whether 0-antigen accumulates on the membranes.
Even though P-NAcMur-pentapeptide translocase and GCL-PP-Gal synthetase appear to interact with different pools of P-GCL at any given time, we cannot exclude the possibility that GCL-PP-Gal synthetase is controlled in rfa mutants to prevent the eventual disruption of peptidoglycan synthesis by the accumulation of glycosylated carrier lipid. The P-GCL pools available to P-NAcMur-pentapeptide translocase are not depleted during relatively short periods of accumulation of 0-antigen fragments (10 to 20 min). However, 0-antigen accumulation for prolonged time intervals might depress peptidoglycan synthesis if glycosylated carrier lipid diffused slowly through the membrane and de novo synthesis were not sufficient to maintain a critical level of P-GCL. If sufficiently large amounts of glycosylated carrier lipid were to accumulate, the rfa mutations would prove lethal to the cell. A mechanism by which GCL-PP-Gal synthetase activity responds to the state of LPS core biosynthesis would protect the cell from lethal accumulation of 0-antigen fragments. Again, one of the most effective mechanisms for the coordination of core synthesis and GCL-PP-Gal synthetase activity would be at the level of insertion of the enzymes into the membrane matrix.
